A shadow market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Experimental Drug Acquiring Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these accounts privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where communities with numerous of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers market the substance there before directing customers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Experts Express Worries
However, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could result in individuals injecting products of unknown origin.
Several professionals said the popularity for the experimental drug could be connected to the increasing cost of approved weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.
Some content creators try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, marketing, and customer laws, potentially leading to penalties, legal action or imprisonment.
Service Response and Material Elimination
According to the social media company, the service has taken down violative content and banned related keywords and query recommendations. The organization stated it was dedicated to maintaining the service secure and allocating resources in enhancing compliance measures.
Digital Trading Operations
Investigations also found communities with up to 9,000 participants selling the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, populated with images of slimming results, positive testimonials and detailed instructions for mixing or administering at home.
Within minutes of joining one group, a vendor shared WhatsApp details, where most transactions occur. The seller sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about body mass, health issues or past usage.
Product Information and Pricing
Inside these communities, posts display dark colored parcels with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20mg. When questioned how long a pen should last, vendors give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for Telegram stated it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering substances they cannot confirm. Although the research behind retatrutide is sound, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.
Her staff has already encountered patients harmed by personal administration from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to potentially serious medical dangers”.
